Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1991 1
1994 1
1995 5
1996 1
1997 3
1998 6
1999 6
2000 6
2001 7
2002 4
2003 14
2004 12
2005 12
2006 15
2007 9
2008 13
2009 15
2010 15
2011 17
2012 19
2013 15
2014 23
2015 29
2016 39
2017 40
2018 55
2019 47
2020 72
2021 70
2022 67
2023 61
2024 23

Text availability

Article attribute

Article type

Publication date

Search Results

633 results

Results by year

Filters applied: . Clear all
Page 1
European Society for Radiotherapy and Oncology Advisory Committee in Radiation Oncology Practice consensus recommendations on patient selection and dose and fractionation for external beam radiotherapy in early breast cancer.
Meattini I, Becherini C, Boersma L, Kaidar-Person O, Marta GN, Montero A, Offersen BV, Aznar MC, Belka C, Brunt AM, Dicuonzo S, Franco P, Krause M, MacKenzie M, Marinko T, Marrazzo L, Ratosa I, Scholten A, Senkus E, Stobart H, Poortmans P, Coles CE. Meattini I, et al. Among authors: belka c. Lancet Oncol. 2022 Jan;23(1):e21-e31. doi: 10.1016/S1470-2045(21)00539-8. Lancet Oncol. 2022. PMID: 34973228 Review.
ESTRO-EANO guideline on target delineation and radiotherapy details for glioblastoma.
Niyazi M, Andratschke N, Bendszus M, Chalmers AJ, Erridge SC, Galldiks N, Lagerwaard FJ, Navarria P, Munck Af Rosenschöld P, Ricardi U, van den Bent MJ, Weller M, Belka C, Minniti G. Niyazi M, et al. Among authors: belka c. Radiother Oncol. 2023 Jul;184:109663. doi: 10.1016/j.radonc.2023.109663. Epub 2023 Apr 13. Radiother Oncol. 2023. PMID: 37059335 Free article.
Radiotherapy of oligometastatic prostate cancer: a systematic review.
Rogowski P, Roach M 3rd, Schmidt-Hegemann NS, Trapp C, von Bestenbostel R, Shi R, Buchner A, Stief C, Belka C, Li M. Rogowski P, et al. Among authors: belka c. Radiat Oncol. 2021 Mar 9;16(1):50. doi: 10.1186/s13014-021-01776-8. Radiat Oncol. 2021. PMID: 33750437 Free PMC article.
ESTRO-ACROP guideline "target delineation of glioblastomas".
Niyazi M, Brada M, Chalmers AJ, Combs SE, Erridge SC, Fiorentino A, Grosu AL, Lagerwaard FJ, Minniti G, Mirimanoff RO, Ricardi U, Short SC, Weber DC, Belka C. Niyazi M, et al. Among authors: belka c. Radiother Oncol. 2016 Jan;118(1):35-42. doi: 10.1016/j.radonc.2015.12.003. Epub 2016 Jan 6. Radiother Oncol. 2016. PMID: 26777122
ESTRO ACROP guidelines for target volume definition in pancreatic cancer.
Brunner TB, Haustermans K, Huguet F, Morganti AG, Mukherjee S, Belka C, Krempien R, Hawkins MA, Valentini V, Roeder F. Brunner TB, et al. Among authors: belka c. Radiother Oncol. 2021 Jan;154:60-69. doi: 10.1016/j.radonc.2020.07.052. Epub 2020 Aug 28. Radiother Oncol. 2021. PMID: 32861703
APOBEC-mediated mutagenesis is a favorable predictor of prognosis and immunotherapy for bladder cancer patients: evidence from pan-cancer analysis and multiple databases.
Shi R, Wang X, Wu Y, Xu B, Zhao T, Trapp C, Wang X, Unger K, Zhou C, Lu S, Buchner A, Schulz GB, Cao F, Belka C, Su C, Li M, Shu Y. Shi R, et al. Among authors: belka c. Theranostics. 2022 May 16;12(9):4181-4199. doi: 10.7150/thno.73235. eCollection 2022. Theranostics. 2022. PMID: 35673559 Free PMC article.
Recommendations for radiation therapy in oligometastatic prostate cancer: An ESTRO-ACROP Delphi consensus.
Zilli T, Achard V, Dal Pra A, Schmidt-Hegemann N, Jereczek-Fossa BA, Lancia A, Ingrosso G, Alongi F, Aluwini S, Arcangeli S, Blanchard P, Conde Moreno A, Couñago F, Créhange G, Dirix P, Gomez Iturriaga A, Guckenberger M, Pasquier D, Sargos P, Scorsetti M, Supiot S, Tree AC, Zapatero A, Le Guevelou J, Ost P, Belka C. Zilli T, et al. Among authors: belka c. Radiother Oncol. 2022 Nov;176:199-207. doi: 10.1016/j.radonc.2022.10.005. Epub 2022 Oct 10. Radiother Oncol. 2022. PMID: 36228761 Free article.
First Clinical Results for PSMA-Targeted α-Therapy Using 225Ac-PSMA-I&T in Advanced-mCRPC Patients.
Zacherl MJ, Gildehaus FJ, Mittlmeier L, Böning G, Gosewisch A, Wenter V, Unterrainer M, Schmidt-Hegemann N, Belka C, Kretschmer A, Casuscelli J, Stief CG, Unterrainer M, Bartenstein P, Todica A, Ilhan H. Zacherl MJ, et al. Among authors: belka c. J Nucl Med. 2021 May 10;62(5):669-674. doi: 10.2967/jnumed.120.251017. Epub 2020 Oct 2. J Nucl Med. 2021. PMID: 33008928 Free article.
633 results